Key result
The C-Pulse System significantly improved mean left ventricular ejection fraction from 24.3% to 44.5% over 6 months in patients with moderate-to-severe heart failure.
Observational (n=8)
Yes
Answers are grounded in this paper and cite their sources.
In a small preliminary cohort, the extra-aortic balloon counterpulsation system demonstrated safety and significantly improved left ventricular ejection fraction and quality of life at 6 months in patients with moderate-to-severe heart failure.
BACKGROUND The C-Pulse System is an extra-aortic balloon counterpulsation device. It is used to treat patients with heart failure disease in NYHA functional class III or ambulatory class IV. MATERIAL AND METHODS We present preliminary site-reported 6-month data from 3 centers in Germany as part of the prospective observational post-market OPTIONS HF study. RESULTS Between May 2013 and March 2014, the C-Pulse System was implanted in 8 patients (7 male) with a mean age of 61.6±9.3 years. Four had ischemic and 4 had non-ischemic cardiomyopathy. No stroke, myocardial infarction, major bleeding, or major infection due to the device were reported. One patient developed non-device-related refractory tachycardia with worsening heart failure 12 h after surgery and underwent left ventricular assist device implantation. Within 6 months of observation, functional status improved from NYHA III to II in 5 patients, and 2 remained in NYHA III. Mean left ventricular ejection fraction increased from 24.3±7.9% to 44.5±4.5% (p<0.0001). Mean Kansas City Cardiomyopathy Questionnaire overall score improved from 28.6±19.1 to 59.1±22.5 (p=0.0183). Six-minute walk test was performed in 6 out of 7 patients at follow-up. The mean distance improved from 252.0±85.1 m to 279.2±87.5 m (p>0.05). One patient was weaned off the device after 6 months of support. CONCLUSIONS The C-Pulse System provides a therapeutic option for patients with moderate-to-severe heart failure and seems to improve quality of life and cardiac function over time.
No takes yet. Share an insight, caveat, or question.
Schulz et al. (2016) conducted an observational in Heart Failure (n=8). C-Pulse System vs. Baseline was evaluated on Mean left ventricular ejection fraction (LVEF) at 6 months (p=<0.0001). The C-Pulse System significantly improved mean left ventricular ejection fraction from 24.3% to 44.5% over 6 months in patients with moderate-to-severe heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: